Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
08/2005
08/23/2005US6932961 N-methyl-2-[(1-phenyl-1,2-dihydro[1,4]oxazino[2,3,4-jk]carbazol-7-yl)oxy]-1-ethanamine for example, isotopically labelled; for diagnostic screening using tomography; Central Nervous System (CNS)
08/23/2005US6932960 Complexes with radionuclides; for use as contrast agent in magnetic resonance imaging (MRI); as parasiticide, viricide, or as chelation therapy of iron overload such as thalassemia; optimal combination of lipophilicity and hydrophilicity
08/18/2005WO2005075647A1 Humanized antibody
08/18/2005WO2005075486A1 Method of synthesizing compounds having a phosphorus-fluorine-18 bond
08/18/2005WO2005074996A2 Lat1 transporter expressed in blood brain barrier cells
08/18/2005WO2005060569A3 Tame based chelators and uses thereof
08/18/2005WO2005039647A3 Radium target and method for producing it
08/18/2005WO2004066946A3 Method for evaluating the efficacy of certain cancer treatments
08/18/2005WO2004037296A3 Method for the production of hyperpolarized 129xe
08/18/2005US20050182027 radiolabeled phosphonium or ammonium salts that accumulate in mitochondria of cancer cells; cancer diagnosis; tomography; distinguishes between tissue inflammation and tumors; e.g. F18-3-fluoropropyltriphenyl phosphonium bromide
08/18/2005US20050181447 Opioid metallopeptide compositions and methods
08/18/2005US20050181038 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
08/18/2005US20050180955 gene therapy; delivering recombinant adeno-associated virus virions to the brain; pumping; transgene encodes an aromatic amino acid decarboxylase
08/18/2005US20050180918 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers
08/18/2005CA2555306A1 Humanized antibody
08/18/2005CA2555305A1 Method of synthesizing compounds having a phosphorus-fluorine-18 bond
08/17/2005EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease
08/17/2005EP1563852A1 Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils
08/17/2005EP1562641A2 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
08/17/2005EP1562640A2 Methods for purifying radiolabelled compounds
08/17/2005EP1562637A1 Contrast medium for representing lymph nodes
08/17/2005EP1202945B1 Methods for preparing perfluorinated [18 f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
08/17/2005EP0836618B1 Radiometal-binding analogues of leutenizing hormone releasing hormone
08/16/2005US6930105 Tetracyclicazaindoles and indolines having 5-HT activity
08/11/2005WO2005072781A2 Method and kit for the production of particles labelled with rhenium-188
08/11/2005WO2005072780A2 Cellular labeling for nuclear magnetic resonance techniques
08/11/2005WO2005058247A3 Method for preparing radiolabeled thymidine having low chromophoric byproducts
08/11/2005US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/11/2005US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines
08/11/2005US20050175668 Lapachone delivery systems, compositions and uses related thereto
08/11/2005US20050175582 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
08/11/2005US20050175542 System, formulation, kit and method for tagging colonic residue in an individual
08/11/2005US20050175536 Method for obtaining a 2-18f-fluor-2-deoxy-d-glucose 18f-fdg-solution
08/11/2005US20050175534 Method of synthesizing compounds having a phosphorus-fluorine-18 bond
08/11/2005CA2560544A1 Cellular labeling for nuclear magnetic resonance techniques
08/10/2005EP1560603A1 Method for measuring pancreatic metabolism
08/10/2005EP1560602A1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof
08/10/2005EP1560601A1 Stabilization of radiopharmceuticals labelled with 18-f
08/10/2005EP1560600A1 Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
08/10/2005EP1117351B1 Drug delivery systems
08/10/2005EP1084145B1 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis
08/10/2005EP1051207B1 Radiopaque implantable collagenous biomaterial device
08/10/2005EP1009447B1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
08/10/2005CN1652821A Human monoclonal antibodies to prostate specific membrane antigen (PSMA)
08/09/2005US6928315 Apparatus for impedance imaging coupled with another modality
08/09/2005US6926896 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction
08/09/2005US6926884 GPIb-lipid bond construct and use thereof
08/09/2005US6926883 by reacting a metal in the permetallate form (MO4*form) with carbon monoxide and a reducing agent, soluble in water but not decomposed by water; imaging agent, radionuclide
08/04/2005WO2005070043A2 Methods for treating non-melanoma cancers with paba
08/04/2005WO2005015155A3 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
08/04/2005US20050171023 Apoptosis resistance; protecting healthy cells under environmental stress
08/04/2005US20050169980 Liposomal composition composed of pre-formed liposomes having entrapped therapeutic agent and plurality of targeting conjugates composed of lipid, hydrophilic polymer and targeting ligand; target-cell sensitized liposome composition formed by incubating liposomal composition with selected conjugate
08/04/2005US20050169927 Human tissue factor antibodies
08/04/2005US20050169926 DNA sequence encoding an antibody fusion protein which is useful for the treatment and diagnosis of various cancers, including colon cancer; anticarcinogenic agents; biodrugs
08/04/2005US20050169915 selected from heavy chains, light chains and modified variable regions; breast cancer therapy; detecting using antigen and antibody complex; immunoassay, immunotherapy
08/04/2005US20050169883 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
08/04/2005US20050169837 Coumarines useful as biomarkers
08/04/2005US20050167267 Flow cell, method for separating carrier-free radionuclides, and the radiochemical reaction thereof
08/04/2005CA2553223A1 System and method for expression proteomics based on isotope ratio modification
08/03/2005EP1559725A1 Antigen recognizing antibody
08/03/2005EP1558595A1 Piperazinyl and diazapanyl benzamides and benzthioamides
08/03/2005EP1558293A2 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
08/03/2005EP1558284A1 Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents
08/03/2005CN1649903A Rs7抗体 Rs7 antibody
08/03/2005CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
08/03/2005CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF)
08/03/2005CN1649828A Tumor imaging compounds
08/03/2005CN1649628A Method of encapsulating metal complex within liposomes
08/03/2005CN1647825A Anti-nasopharyngeal carcinoma target coupling preparation and its preparing method
07/2005
07/28/2005WO2005067983A1 Improved gastrin releasing peptide compounds
07/28/2005WO2005067388A2 Perturbed membrane-binding compounds and methods of using the same
07/28/2005US20050164994 Using a drug delivery device containing radiation seeds at predetermined positions and a codrug that has two drug moieties covalently linked, preferably a coitcosteroid linked to a second corticosteroid, an antiproliferative agent, or a non-steroidal antiinflammatory agent; radiotherapy; prostate cancer
07/28/2005US20050164919 Bactericides; peptide antibiotics
07/28/2005US20050164916 Glycopeptide phosphonate derivatives
07/28/2005US20050164914 erectile dysfunction, and female sexual dysfunction; metallopeptide contains aromatic amino acid side chain moieties and does not bind any melanocortin receptor; combination therapy with phosphodiesterase inhibitor or melanocortin receptor MC4-R agonist
07/28/2005US20050164342 Cloned glutamic acid decarboxylase
07/28/2005US20050164278 Breast cancer specific genes (BSG) and diagnosing/preventing cell proliferative disorders; immunotherapy; paramagnetic imaging
07/28/2005US20050164267 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics
07/28/2005US20050163723 Synthesis of small particles
07/28/2005US20050163710 Gastrin receptor-avid peptide conjugates
07/28/2005US20050163707 Radio labelled monoclonal antibody human milk fat globule1, binds selectively to polymorphic epithelial mucin; Taxotere chemotherapeutic agent; administered in combination
07/28/2005CA2553304A1 Perturbed membrane-binding compounds and methods of using the same
07/28/2005CA2549318A1 Improved gastrin releasing peptide compounds
07/27/2005EP1556142A2 Alkyne derivatives as tracers for metabotropic glutamate receptor binding
07/27/2005EP1351961B1 Substituted indolines as 5-ht receptor ligands
07/27/2005EP1257299B1 Radioactive therapeutic liposomes
07/27/2005EP0990000B1 Connective tissue growth factor-3
07/27/2005EP0827411B1 Method of establishing the optimal radiation dose for radiopharmaceutical treatment of disease
07/27/2005CN1646175A Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG) - solution
07/27/2005CN1646160A Anti-alpha V beta 6 antibodies
07/26/2005US6921825 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia
07/26/2005US6921533 Method of using monoclonal antibodies against leukocyte adhesion receptor β-chain
07/26/2005US6921526 Gastrin receptor-avid peptide conjugates
07/26/2005US6921525 Diagnosis of cardiovascular disorders
07/21/2005WO2005065710A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment
07/21/2005WO2005040337A3 METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES
07/21/2005WO2005001415A3 Optically pure and enriched isomers of chelating ligands and contrast agents
07/21/2005WO2003074005A8 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
07/21/2005WO2003057160A8 Compositions and methods for the diagnosis and treatment of tumor
07/21/2005US20050159440 N-substituted groups such as 3-fluoropropyl; 2,2-dimethylethyl; 2-ethoxyethyl; 2-methoxyethyl; 2-propenyl; 2-propynyl; 2-cyanoethyl; 3-cyanopropyl; 3-iodoprop-(2E)-enyl; 3-iodoprop-(2Z)-enyl; therapy for drug abuse, in particular, cocaine abuse; side effect reduction